Exact Mass: 494.1209

Exact Mass Matches: 494.1209

Found 32 metabolites which its exact mass value is equals to given mass value 494.1209, within given mass tolerance error 0.001 dalton. Try search metabolite list with more accurate mass tolerance error 0.0002 dalton.

Salvianolic acid A

(2R)-3-(3,4-dihydroxyphenyl)-2-[(E)-3-[2-[(E)-2-(3,4-dihydroxyphenyl)ethenyl]-3,4-dihydroxyphenyl]prop-2-enoyl]oxypropanoic acid

C26H22O10 (494.1213)


Salvianolic acid A could protect the blood brain barrier through matrix metallopeptidase 9 (MMP-9) inhibition and anti-inflammation. Salvianolic acid A could protect the blood brain barrier through matrix metallopeptidase 9 (MMP-9) inhibition and anti-inflammation.

   

5-Methoxyhydnocarpin

5-Methoxyhydnocarpin-D

C26H22O10 (494.1213)


   

Phenolphthalein glucuronide

3,4,5-trihydroxy-6-{4-[1-(4-hydroxyphenyl)-3-oxo-1,3-dihydro-2-benzofuran-1-yl]phenoxy}oxane-2-carboxylic acid

C26H22O10 (494.1213)


   

Salvianolic acid A

3-(3,4-dihydroxyphenyl)-2-[(3-{2-[2-(3,4-dihydroxyphenyl)ethenyl]-3,4-dihydroxyphenyl}prop-2-enoyl)oxy]propanoic acid

C26H22O10 (494.1213)


   

Salvianolic

BENZENEPROPANOIC ACID, .ALPHA.-(((2E)-3-(2-((1E)-2-(3,4-DIHYDROXYPHENYL)ETHENYL)-3,4-DIHYDROXYPHENYL)-1-OXO-2-PROPENYL)OXY)-3,4-DIHYDROXY-, (.ALPHA.R)-

C26H22O10 (494.1213)


Salvianolic acid A is a stilbenoid. Salvianolic acid A is under investigation in clinical trial NCT03908242 (Phase I Study of Continuous Administration of Salvianolic Acid A Tablet). Salvianolic acid A is a natural product found in Salvia miltiorrhiza, Salvia flava, and other organisms with data available. D004791 - Enzyme Inhibitors > D054328 - Proton Pump Inhibitors D000970 - Antineoplastic Agents Salvianolic acid A could protect the blood brain barrier through matrix metallopeptidase 9 (MMP-9) inhibition and anti-inflammation. Salvianolic acid A could protect the blood brain barrier through matrix metallopeptidase 9 (MMP-9) inhibition and anti-inflammation.

   

5-Methoxyhydnocarpin D

5-Methoxyhydnocarpin D

C26H22O10 (494.1213)


   

Phenolphthalein b-D-glucuronic acid sodium salt

Phenolphthalein b-D-glucuronic acid sodium salt

C26H22O10 (494.1213)


   
   

3,5-Di-Me ether,tri-Ac-3,4,4,5,5-Pentahydroxy-2,7-cycloligna-7,7-dien-9,9-olide

3,5-Di-Me ether,tri-Ac-3,4,4,5,5-Pentahydroxy-2,7-cycloligna-7,7-dien-9,9-olide

C26H22O10 (494.1213)


   

1,2,3-Indantrionemonohydrate

1,2,3-Indantrionemonohydrate

C26H22O10 (494.1213)


   

5-methoxyhydnocarpin

5-methoxyhydnocarpin

C26H22O10 (494.1213)


   

pseudonocardone B

pseudonocardone B

C26H22O10 (494.1213)


   
   

12,13-dihydro-3,4,5,7-tetrahydroxy-12-hydroxymethyl-13-(17-hydroxyl-16,18-dimethoxyphenyl)-7H-benzo[c]xanthen-4-one|falloconvolin B

12,13-dihydro-3,4,5,7-tetrahydroxy-12-hydroxymethyl-13-(17-hydroxyl-16,18-dimethoxyphenyl)-7H-benzo[c]xanthen-4-one|falloconvolin B

C26H22O10 (494.1213)


   

3,4,5,6,8,13-Hexahydro-2-methyl-8,13-dioxo-2,6-epoxy-2H-anthra[2,3-b]oxocin-7,9,11-triyl=triacetate

3,4,5,6,8,13-Hexahydro-2-methyl-8,13-dioxo-2,6-epoxy-2H-anthra[2,3-b]oxocin-7,9,11-triyl=triacetate

C26H22O10 (494.1213)


   

FLUORESCEIN MONO-BETA-D-GALACTOPYRANOSIDE

FLUORESCEIN MONO-BETA-D-GALACTOPYRANOSIDE

C26H22O10 (494.1213)


   

Phenolphthalein β-D-glucuronide

Phenolphthalein β-D-glucuronide

C26H22O10 (494.1213)


   

2,5-Bis[4-(acryloyloxy)benzoyl]isosorbide

2,5-Bis[4-(acryloyloxy)benzoyl]isosorbide

C26H22O10 (494.1213)


   

1-[5-methyl-2-(trifluoromethyl)furan-3-yl]-3-[(2Z)-5-(2-{[6-(1H-1,2,4-triazol-3-ylamino)pyrimidin-4-yl]amino}ethyl)-1,3-thiazol-2(3H)-ylidene]urea

1-[5-methyl-2-(trifluoromethyl)furan-3-yl]-3-[(2Z)-5-(2-{[6-(1H-1,2,4-triazol-3-ylamino)pyrimidin-4-yl]amino}ethyl)-1,3-thiazol-2(3H)-ylidene]urea

C18H17F3N10O2S (494.1209)


   

96574-01-5

Benzenepropanoic acid, alpha-((3-(2-(2-(3,4-dihydroxyphenyl)ethenyl)-3,4-dihydroxyphenyl)-1-oxo-2-propenyl)oxy)-3,4-dihydroxy-, (R-(E,E))-

C26H22O10 (494.1213)


D004791 - Enzyme Inhibitors > D054328 - Proton Pump Inhibitors D000970 - Antineoplastic Agents Salvianolic acid A could protect the blood brain barrier through matrix metallopeptidase 9 (MMP-9) inhibition and anti-inflammation. Salvianolic acid A could protect the blood brain barrier through matrix metallopeptidase 9 (MMP-9) inhibition and anti-inflammation.

   

Salvianolicacid A

Salvianolicacid A

C26H22O10 (494.1213)


   

5-methoxyhydnocarpin-D

5-methoxyhydnocarpin-D

C26H22O10 (494.1213)


A flavonolignan isoalted from Mimosa diplotricha.

   

5,7-dihydroxy-2-[3-(4-hydroxy-3-methoxyphenyl)-2-(hydroxymethyl)-8-methoxy-2,3-dihydro-1,4-benzodioxin-6-yl]chromen-4-one

5,7-dihydroxy-2-[3-(4-hydroxy-3-methoxyphenyl)-2-(hydroxymethyl)-8-methoxy-2,3-dihydro-1,4-benzodioxin-6-yl]chromen-4-one

C26H22O10 (494.1213)


   

3-(3,4-dihydroxyphenyl)-2-{[(2e)-3-{2-[(1e)-2-(3,4-dihydroxyphenyl)ethenyl]-3,4-dihydroxyphenyl}prop-2-enoyl]oxy}propanoic acid

3-(3,4-dihydroxyphenyl)-2-{[(2e)-3-{2-[(1e)-2-(3,4-dihydroxyphenyl)ethenyl]-3,4-dihydroxyphenyl}prop-2-enoyl]oxy}propanoic acid

C26H22O10 (494.1213)


   

5'-methoxyhydnocarpin

5'-methoxyhydnocarpin

C26H22O10 (494.1213)


   

(2s,3s,4s,5r,6s)-3,4,5-trihydroxy-6-[(8-methoxy-3-methyl-7,12-dioxotetraphen-1-yl)oxy]oxane-2-carboxylic acid

(2s,3s,4s,5r,6s)-3,4,5-trihydroxy-6-[(8-methoxy-3-methyl-7,12-dioxotetraphen-1-yl)oxy]oxane-2-carboxylic acid

C26H22O10 (494.1213)


   

3,4,5-trihydroxy-6-[(8-methoxy-3-methyl-7,12-dioxotetraphen-1-yl)oxy]oxane-2-carboxylic acid

3,4,5-trihydroxy-6-[(8-methoxy-3-methyl-7,12-dioxotetraphen-1-yl)oxy]oxane-2-carboxylic acid

C26H22O10 (494.1213)


   

(2s)-3-(3,4-dihydroxyphenyl)-2-{[(2e)-3-{2-[(1e)-2-(3,4-dihydroxyphenyl)ethenyl]-3,4-dihydroxyphenyl}prop-2-enoyl]oxy}propanoic acid

(2s)-3-(3,4-dihydroxyphenyl)-2-{[(2e)-3-{2-[(1e)-2-(3,4-dihydroxyphenyl)ethenyl]-3,4-dihydroxyphenyl}prop-2-enoyl]oxy}propanoic acid

C26H22O10 (494.1213)


   

5''-methoxyhydnocarpin-d

5''-methoxyhydnocarpin-d

C26H22O10 (494.1213)


   

5,7-dihydroxy-2-[2-(4-hydroxy-3,5-dimethoxyphenyl)-3-(hydroxymethyl)-2,3-dihydro-1,4-benzodioxin-6-yl]chromen-4-one

5,7-dihydroxy-2-[2-(4-hydroxy-3,5-dimethoxyphenyl)-3-(hydroxymethyl)-2,3-dihydro-1,4-benzodioxin-6-yl]chromen-4-one

C26H22O10 (494.1213)


   

5,7-dihydroxy-2-[(2r,3r)-2-(4-hydroxy-3,5-dimethoxyphenyl)-3-(hydroxymethyl)-2,3-dihydro-1,4-benzodioxin-6-yl]chromen-4-one

5,7-dihydroxy-2-[(2r,3r)-2-(4-hydroxy-3,5-dimethoxyphenyl)-3-(hydroxymethyl)-2,3-dihydro-1,4-benzodioxin-6-yl]chromen-4-one

C26H22O10 (494.1213)


   

2,5,6-tris(acetyloxy)-4'-hydroxy-4-(4-hydroxyphenyl)-[1,1'-biphenyl]-3-yl acetate

2,5,6-tris(acetyloxy)-4'-hydroxy-4-(4-hydroxyphenyl)-[1,1'-biphenyl]-3-yl acetate

C26H22O10 (494.1213)